OpenFilings

ALNYLAM PHARMACEUTICALS, INC.

Form10-K

Report Period2023-12-31

Date Filed2024-02-15

Time Filed16:23:12

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-97
Filing on SEC Edgar